Detection of nucleic acids by target-specific hybrid capture method

• US 7,601,497 B2
• Filed: 11/07/2005
• Issued: 10/13/2009
• Est. Priority Date: 06/15/2000
• Status: Expired due to Fees

• Current Assignee: QIAGEN Gaithersburg, Inc. (Qiagen NV)
• Original Assignee: QIAGEN Gaithersburg, Inc. (Qiagen NV)
• Inventors: Lowe, Brian, Nazarenko, Irina, Lorincz, Attila, Thai, Ha, Eder, Paul, Mallonee, Richard
• Primary Examiner(s): Chunduru; Suryaprabha
• Application Number:
  US11/269,003
• Publication Number:
  US 20060051809A1
• Time in Patent Office: 1,436 Days
• Field of Search: 435/6, 435/91.2, 536/24.31, 536/24.32, 536/24.33
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/6804 Nucleic acid analysis using immunogens immunoassay G01N33/53
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 1/708 for papilloma
• CPC Class Codes: C12Q 2522/101 Single or double stranded nucleic acid binding proteins
• CPC Class Codes: C12Q 2525/121 incorporating both deoxyribonucleotides and ribonucleotides
• CPC Class Codes: C12Q 2525/186 incorporating a non-extendable or blocking moiety
• CPC Class Codes: C12Q 2537/119 Triple helix formation
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2565/519 characterised by the capture moiety being a single stranded oligonucleotide
• CPC Class Codes: C12Q 2565/543 characterised by the use of two or more capture oligonucleotide primers in concert, e.g. bridge amplification

Abstract

Target-specific hybrid capture (TSHC) provides a nucleic acid detection method that is not only rapid and sensitive, but is also highly specific and capable of discriminating highly homologous nucleic acid target sequences. The method produces DNA:RNA hybrids which can be detected by a variety of methods.

Claims

1. A method of detecting at least one target nucleic acid comprising:

a) forming a plurality of enriched target nucleic acids comprising

i) mixing the at least one target nucleic acid with a nucleic acid probe complementary to at least a portion of the at least one target nucleic acid to form a target DNA;

RNA hybrid, wherein when the target nucleic acid is RNA, the probe is DNA, and wherein when the target nucleic acid is DNA, the probe is RNA;

ii) capturing the target DNA;

RNA hybrid onto a solid support; and

iii) removing any nucleic acid that does not form the target DNA;

RNA hybrid or that is not captured onto the solid support to form the plurality of enriched target nucleic acids;

b) amplifying the plurality of enriched target nucleic acids from step a) to form a plurality of amplified targets; and

c) detecting the at least one target nucleic acid in the plurality of amplified targets by

i) mixing the plurality of amplified targets with a selectable oligonucleotide and a nucleic acid probe, wherein the selectable oligonucleotide hybridizes to a first portion of the amplified targets and wherein the nucleic acid probe is complementary to a second portion of the amplified targets wherein if the amplified target is DNA, the selectable oligonucleotide and the nucleic acid probe is RNA and if the amplified target is RNA, the selectable oligonucleotide and the nucleic acid probe is DNA to form a DNA;

RNA hybrid target/oligonucleotide/probe complex, wherein the first portion of the amplified targets and the second portion of the amplified targets are different; and

ii) detecting the DNA;

RNA hybrid target/oligonucleotide/probe complex by a DNA;

RNA hybrid-specific binding agent, to detect at least one target nucleic acid.

2. The method according to claim 1, wherein in the capturing step (a), the solid support is conjugated to a DNA:

RNA hybrid-specific binding agent, thereby capturing the at least one target nucleic acid to a solid support.

3. The method according to claim 1, wherein the DNA:

RNA hybrid-specific binding agent is selected from the group consisting of;

a DNA;

RNA hybrid-specific antibody, a monoclonal or polyclonal antibody, or fragments thereof, a protein, a catalytically inactive RNase H, a nucleic acid, a nucleic acid aptamer, and an oligonucleotide, and wherein the DNA;

RNA hybrid specific binding agent binds to the DNA;

RNA hybrid form a triplex structure.

4. The method according to claim 2, wherein the DNA:

RNA hybrid-specific binding agent is a DNA;

RNA hybrid-specific antibody.

5. The method according to claim 2, wherein the DNA:

RNA hybrid-specific binding agent is a nucleic acid probe complementary to the target nucleic acid.

6. The method according to claim 3, wherein the DNA:

RNA hybrid-specific binding agent is detectably labeled.

7. The method according to claim 6, wherein the label is detected by:

colorimetry, chemiluminescence, fluorescence, and or light-scattering methods.

8. The method according to claim 1, wherein the amplifying is by isothermal amplification.

9. The method according to claim 8, wherein DNA polymerase is used in the isothermal amplification.

10. The method according to claim 8, wherein random primers are used in the isothermal amplification.

11. The method according to claim 10, wherein the random primers are pentamers.

12. The method according to claim 10, wherein the random primers contain a subset of primer sequences specific for a disease.

13. The method according to claim 1, wherein the selectable oligonucleotides are bound to a solid support.

14. The method according to claim 1, wherein the solid support is selected from the group consisting of a plate, microplate, microtiter plate, slide, dish, bead, particle, microparticle, cup, strand, chip, microchip, strip, membrane, microarray, and test tube.

15. The method according to claim 14, wherein the solid support is made of material selected from the group consisting of:

glass, silicon, plastic, polystyrene, polyethylene, polypropylene, and polycarbonate.

16. The method according to claim 14, wherein the solid support is modified to contain a carboxyl, amino, hydrazide, aldehyde groups, nucleic acid or nucleotide derivatives, primary amino group, or dye.

17. The method according to claim 1, further comprising adding a blocker probe.

22. The method of claim 1, wherein the nucleic acid probes complementary to at least a portion of the target nucleic acids and oligonucleotide sequences comprise SEQ ID NO:

1.

25. A method of claim 1, wherein said nucleic acid probe is at least 7500 complementary to said at least one target nucleic acid.

26. A method of claim 1, wherein said nucleic acid probe comprises less than 50% sequence identity, to undesirable non-target sequences.

18. A method of detecting each of at least one target nucleic acid comprising:

a) hybridizing the at least one target nucleic acid to a nucleic acid probe that is complementary to at least a portion of the target nucleic acid, to form a target DNA;

RNA hybrid wherein when the target nucleic acid is RNA, the probe is DNA, and wherein the target nucleic acid is DNA, the probe is RNA;

b) capturing the target DNA;

RNA hybrid with a DNA;

RNA hybrid-specific antibody conjugated to a solid support;

c) separating unbound target nucleic acid from the captured target DNA;

RNA hybrid;

d) amplifying the captured target DNA;

RNA hybrid to form a plurality of amplified targets, wherein the amplifying uses random primers and DNA polymerase;

e) hybridizing a nucleic acid probe complementary to a first portion of the amplified targets to form an amplified DNA;

RNA hybrid;

I) hybridizing an oligonucleotide conjugated to a solid support to a second portion of the amplified DNA;

RNA hybrid, wherein the solid support is selectable; and

g) selecting amplified DNA;

RNA hybrid by the selectable solid support; and

h) detecting the at least one target nucleic acid by binding a DNA;

RNA hybrid-specific binding agent to the amplified DNA;

RNA hybrid, wherein the presence of the amplified DNA;

RNA hybrid is indicative of the presence of the target nucleic acid.

19. The method according to claim 18, wherein the solid support conjugated to an oligonucleotide is a distinguishable bead.

20. The method according to claim 19, wherein the distinguishable bead has a detectable label selected from the group consisting of a fluorescent label, a gold label, and an enzyme label.

21. A multiplex method of detecting at least one target DNA comprising:

a) hybridizing at least one target DNA to at least one first RNA probe which is complementary to at least a portion of the at least one target DNA, to form at least one DNA;

RNA hybrid;

b) capturing the at least one DNA;

RNA hybrid with at least one DNA;

RNA hybrid-specific antibody conjugated to a bead;

c) separating unbound nucleic acid from the at least one DNA;

RNA hybrid, to form at least one enriched target;

d) amplifying the at least one enriched target DNA, to form at least one amplified target DNA, using random primers and DNA polymerase;

e) hybridizing a second RNA probe complementary to a first portion of the amplified target DNA to form an amplified DNA;

RNA hybrid;

f) hybridizing a DNA oligonucleotide to a second portion of the amplified target DNA, wherein the DNA oligonucleotide is conjugated to at least one selectable bead; and

g) detecting the at least one amplified target DNA by binding a DNA;

RNA hybrid-specific antibody to the amplified DNA;

RNA hybrid and selecting the amplified target based on the particular selectable bead.

23. A method of detecting at least one target nucleic acid comprising:

a) forming a plurality of enriched target nucleic acids comprising

i) mixing the at least one target nucleic acid with a nucleic acid probe complementary to at least one unique region of the at least one target nucleic acid to form a target DNA;

RNA hybrid whereby the probe comprises a nucleic acid sequence that hybridizes to said at least one unique region, and wherein when the target nucleic acid is RNA, the probe is DNA, and wherein when the target nucleic acid is DNA, the probe is RNA;

ii) capturing the target DNA;

RNA hybrid onto a solid support; and

iii) removing any nucleic acid that does not form the target DNA;

RNA hybrid or that is not captured onto the solid support to form the plurality of enriched target nucleic acids;

b) amplifying the plurality of enriched target nucleic acids from step a) to form a plurality of amplified targets; and

c) detecting the at least one target nucleic acid in the plurality of amplified targets by

i) mixing the plurality of amplified targets with a selectable oligonucleotide and a nucleic acid probe, wherein the selectable oligonucleotide hybridizes to a first portion of the amplified targets and wherein the nucleic acid probe is complementary to a second portion of the amplified targets wherein if the amplified target is DNA, the selectable oligonucleotide and the nucleic acid probe is RNA and if the amplified target is RNA, the selectable oligonucleotide and the nucleic acid probe is DNA to form a DNA;

RNA hybrid target/oligonucleotide/probe complex;

wherein the first portion of the amplified targets and the second portion of the amplified targets are different; and

ii) detecting the DNA;

RNA hybrid target/oligonucleotide/probe complex by a DNA;

RNA hybrid-specific binding agent, to detect at least one target nucleic acid.

24. A method of detecting at least one target nucleic acid comprising:

a) forming a plurality of enriched target nucleic acids comprising

i) mixing the at least one target nucleic acid with a nucleic acid probe complementary to at least a portion of the at least one target nucleic acid to form a target DNA;

RNA hybrid, wherein when the target nucleic acid is RNA, the probe is DNA, and wherein when the target nucleic acid is DNA, the probe is RNA; and

wherein the probe is specific to the target nucleic acid;

ii) capturing the target DNA;

RNA hybrid onto a solid support; and

iii) removing any nucleic acid that does not form the target DNA;

RNA hybrid or that is not captured onto the solid support to form the plurality of enriched target nucleic acids;

b) amplifying the plurality of enriched target nucleic acids from step a) to form a plurality of amplified targets; and

c) detecting the at least one target nucleic acid in the plurality of amplified targets by

i) mixing the plurality of amplified targets with a selectable oligonucleotide and a nucleic acid probe, wherein the selectable oligonucleotide hybridizes to a first portion of the amplified targets and wherein the nucleic acid probe is complementary to a second portion of the amplified targets wherein if the amplified target is DNA, the selectable oligonucleotide and the nucleic acid probe is RNA and if the amplified target is RNA, the selectable oligonucleotide and the nucleic acid probe is DNA to form a DNA;

RNA hybrid target/oligonucleotide/probe complex;

wherein the first portion of the amplified targets and the second portion of the amplified targets are different; and

ii) detecting the DNA;

RNA hybrid target/oligonucleotide/probe complex by a DNA;

RNA hybrid-specific binding agent, to detect at least one target nucleic acid.